Metamark, Definiens Partner on Cancer Dx
June 30, 2011
Metamark, Definiens Partner on Cancer Dx
The collaboration will combine Metamark's multiplex protein detection platform with image analysis technology that the firm will jointly develop with Definiens.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.